Abstract:
Objective To investigate the prognostic significance of Circ_0001946 expression in pancreatic cancer patients.
Methods The expression of Circ_0001946 in pancreatic cancer tissues and serum samples were detected by qRT-PCR, and the relation between Circ_0001946 and various clinicopathological parameters was analyzed by Chi-Square test. Kaplan-Meier method was used to analyze the relation between Circ_0001946 expression and survival time and prognosis. Univariate and multivariate Cox proportional risk models were used to analyze the factors affecting the prognosis of pancreatic cancer patients, and ROC curve was used to analyze its effect as a biomarker for early diagnosis of pancreatic cancer.
Results Circ_0001946 was highly expressed in pancreatic cancer tissues and serum (all P < 0.0001). Circ_0001946 was significantly associated with vascular thrombosis, lymphatic metastasis, CA199 expression and disease stage (all P < 0.05). Serum Circ_0001946 expression was positively correlated with AFP (r=0.765, P=0.000). The area under the ROC curve of Circ_0001946 as a serum marker for the diagnosis of pancreatic cancer was 0.805(95% CI:0.754-0.927, P=0.000). The overall survival and progressive-free survival of patients with high Circ_0001946 expression were significantly shorter than those with low Circ_0001946 expression (all P=0.000). Univariate and multivariate Cox regression analyses showed that disease stage, Circ_0001946 expression and vascular thrombus were independent prognostic factors for pancreatic cancer patients.
Conclusion Circ_0001946 is highly expressed in pancreatic cancer tissues and related to the prognosis of patients.